The Current Ratio as of December 2025 (TTM) for InnoPharmax Inc. (4172.TWO) is 6.80

According to InnoPharmax Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.80. This represents a change of 0.49% compared to the average of 6.77 of the last 4 quarters.

InnoPharmax Inc. (4172.TWO) Historical Current Ratio (quarterly & annually)

How has 4172.TWO Current Ratio performed in the past?

The mean historical Current Ratio of InnoPharmax Inc. over the last ten years is 6.05. The current 6.80 Current Ratio has changed 11.15% with respect to the historical average. Over the past ten years (40 quarters), 4172.TWO's Current Ratio was at its highest in in the June 2023 quarter at 14.55. The Current Ratio was at its lowest in in the June 2022 quarter at 0.

InnoPharmax Inc. (4172.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of InnoPharmax Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InnoPharmax Inc. (4172.TWO) Average Current Ratio

How has 4172.TWO Current Ratio performed in the past?

The current Current Ratio of InnoPharmax Inc. (4172.TWO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

InnoPharmax Inc. (4172.TWO) Current Ratio vs. Peers

How is 4172.TWO’s Current Ratio compared to its peers?

InnoPharmax Inc.’s Current Ratio is greater than Winston Medical Supply Co., Ltd. (1.60), less than LIWANLI Innovation Co., Ltd. (13.30), greater than TSH Biopharm Corporation Limited (4.94), greater than Golden Biotechnology Corporation (0.54), greater than Allied Biotech Corporation (1.51), greater than Chunghwa Chemical Synthesis & Biotech Co., Ltd. (2.82), greater than GeneFerm Biotechnology Co., Ltd. (4.03), less than Advagene Biopharma Co., Ltd. (30.83), greater than Shangya Technology Co., Ltd. (3.05), greater than Sunny Pharmtech Inc. (1.30),

Build a custom stock screener for InnoPharmax Inc. (4172.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InnoPharmax Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InnoPharmax Inc. (4172.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InnoPharmax Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.